Publication | Closed Access

A clinical trial of aminoglutethimide in advanced postmenopausal breast carcinoma: Low response in patients previously treated with medroxyprogesterone

Breast OncologyMedicinePharmacologyGynecologyBreast CancerPharmacotherapyMenopauseOncologyLow ResponseCancer ResearchEndocrine-related Cancer